Extracellular vesicles from activated platelets: a semiquantitative cryo-electron microscopy and immuno-gold labeling study

ABSTRACT Cells release membrane vesicles in their surrounding medium either constitutively or in response to activating signals. Two main types of extracellular vesicles (EVs) are commonly distinguished based on their mechanism of formation, membrane composition and size. According to the current model, EVs shed from the plasma membrane, often called microvesicles, expose phosphatidylserine (PS) and range in size from 100 nm to 1 µm, while EVs originating from endosomal multi-vesicular bodies, called exosomes, contain tetraspanin proteins, including CD63, and range in size from 50 to 100 nm. Heijnen et al. [1] have shown that activated platelets release EVs corresponding to these two types of vesicles, using negative staining electron microscopy (EM) and immuno-gold labeling. Here, we apply cryo-EM and immuno-gold labeling to provide a quantitative analysis of EVs released by platelets activated by thrombin, TRAP and CRP-XL, as well as EVs from serum. We show that EVs activated by these three agonists present a similar size distribution, the majority of them forming a broad peak extending from 50 nm to 1 µm, about 50% of them ranging from 50 to 400 nm. We show also that 60% of the EVs from TRAP or CRP-XL activation expose CD41, a majority of them exposing also PS. To explain the presence of large EVs CD41-negative or PS-negative, several alternative mechanisms of EV formation are proposed. We find also that the majority of EVs in activated platelet samples expose CD63, and distinguish two populations of CD63-positive EVs, namely large EVs with low labeling density and small EVs with high labeling density.

[1]  R. Cardigan,et al.  Microparticle sizing by dynamic light scattering in fresh‐frozen plasma , 2009, Vox sanguinis.

[2]  A. Brisson,et al.  A simple flow cytometry method improves the detection of phosphatidylserine-exposing extracellular vesicles , 2014, Journal of thrombosis and haemostasis : JTH.

[3]  C. Reutelingsperger,et al.  Ultrastructural Detection of Surface Exposed Phosphatidylserine on Activated Blood Platelets , 1995, Thrombosis and Haemostasis.

[4]  Y Komiyama,et al.  High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles. , 1996, Blood.

[5]  M. Gelb,et al.  Platelets release mitochondria serving as substrate for bactericidal group IIA-secreted phospholipase A2 to promote inflammation. , 2014, Blood.

[6]  Anikó Szalai,et al.  Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. , 2011, Blood.

[7]  C. Esmon,et al.  Assembly of the platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. , 1989, The Journal of biological chemistry.

[8]  L. Horstman,et al.  Platelet microparticles: a wide-angle perspective. , 1999, Critical reviews in oncology/hematology.

[9]  J H Hartwig,et al.  Mechanisms of actin rearrangements mediating platelet activation , 1992, The Journal of cell biology.

[10]  E. Chargaff,et al.  The biological significance of the thromboplastic protein of blood. , 1946, The Journal of biological chemistry.

[11]  C. Théry,et al.  Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation , 2012, Journal of extracellular vesicles.

[12]  Paul Harrison,et al.  Classification, Functions, and Clinical Relevance of Extracellular Vesicles , 2012, Pharmacological Reviews.

[13]  P. Comfurius,et al.  Changes in membrane phospholipid distribution during platelet activation. , 1983, Biochimica et biophysica acta.

[14]  Alain Brisson,et al.  Fluorescence triggering: A general strategy for enumerating and phenotyping extracellular vesicles by flow cytometry , 2016, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[15]  J. Freyssinet,et al.  Cellular Mechanisms Underlying the Formation of Circulating Microparticles , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Loundou,et al.  Platelet and not erythrocyte microparticles are procoagulant in transfused thalassaemia major patients , 2015, British journal of haematology.

[17]  J J Sixma,et al.  Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. , 1999, Blood.

[18]  J. Tait,et al.  A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer , 2011, Journal of thrombosis and haemostasis : JTH.

[19]  P. Wolf The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[20]  D. Gibson,et al.  Measurement of the affinity and cooperativity of annexin V-membrane binding under conditions of low membrane occupancy. , 2004, Analytical biochemistry.

[21]  Paul J. Harrison,et al.  Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis , 2011, Nanomedicine : nanotechnology, biology, and medicine.

[22]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[23]  Ç. Gerçel-Taylor,et al.  Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments , 2011, Seminars in Immunopathology.

[24]  Richard W. Farndale,et al.  Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production , 2010, Science.

[25]  R. Johnstone Revisiting the road to the discovery of exosomes. , 2005, Blood cells, molecules & diseases.

[26]  A. Schroit,et al.  Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. , 1997, Blood.

[27]  R. Nieuwland,et al.  Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.

[28]  Lynne T. Bemis,et al.  Standardization of sample collection, isolation and analysis methods in extracellular vesicle research , 2013, Journal of extracellular vesicles.

[29]  C. Théry,et al.  Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes , 2016, Proceedings of the National Academy of Sciences.

[30]  T. Oosterkamp,et al.  Determination of the size distribution of blood microparticles directly in plasma using atomic force microscopy and microfluidics , 2012, Biomedical Microdevices.

[31]  J. Tait,et al.  Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. , 1991, The Journal of biological chemistry.

[32]  S. Mornet,et al.  Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration , 2014, Journal of thrombosis and haemostasis : JTH.

[33]  P. Altevogt,et al.  Exosomes as a potential tool for a specific delivery of functional molecules. , 2013, Methods in molecular biology.

[34]  Chungho Kim,et al.  The final steps of integrin activation: the end game , 2010, Nature Reviews Molecular Cell Biology.

[35]  A. Booth,et al.  Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane , 2006, The Journal of cell biology.

[36]  H. Geuze,et al.  Selective Enrichment of Tetraspan Proteins on the Internal Vesicles of Multivesicular Endosomes and on Exosomes Secreted by Human B-lymphocytes* , 1998, The Journal of Biological Chemistry.

[37]  M. Sefton,et al.  Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect. , 1993, The Journal of biological chemistry.

[38]  Graça Raposo,et al.  Extracellular vesicles: Exosomes, microvesicles, and friends , 2013, The Journal of cell biology.

[39]  É. Boilard,et al.  The diversity of platelet microparticles , 2015, Current opinion in hematology.